London, Feb 16, 2026, 14:50 GMT — Regular session
- JTC picked up 0.15% to 1,294 pence, though the stock remains stuck beneath that 1,340p cash bid.
- JPMorgan said its total exposure climbed to roughly 6.29%, most of that coming through derivatives.
- Vanguard disclosed a 5.07% stake, as required by UK takeover regulations.
JTC ticked up 0.15% to 1,294 pence by 14:34 GMT, shares hovering between 1,292 and 1,296 pence as new takeover filings surfaced.
Jersey-based professional services group JTC is currently in an offer period, having accepted a recommended cash deal at 13.40 pounds per share (1,340 pence). The group expects the acquisition to close in the third quarter of 2026, pending regulatory sign-off. Chief executive Nigel Le Quesne, in a previous update, pointed to “another record year of new business wins” in 2025 and said the company was “pleased with our progress.” JTC
The stock’s behaving more like a merger play these days than a growth bet. Investors are focused on the spread versus the offer price, scanning for signals on whether approvals might accelerate or hit delays.
JPMorgan Chase & Co bumped its stake to 6.286% as of Feb. 11, up from 6.156% previously, according to a TR-1 notification. The filing splits that total between a modest direct shareholding and a bigger chunk held via cash-settled equity swaps and similar derivatives, which mirror the share price but don’t involve owning the stock itself.
Vanguard has flagged a 5.07% stake—8,742,207 shares—in a recent Form 8.3 filing under the UK Takeover Code, dated Feb. 13. The fund manager reported a handful of trades too: it picked up 2,400 shares and offloaded 14,004, with transactions crossing at about 12.90 to 12.92 pounds.
JTC, split between institutional and private client divisions, handles fund, corporate, and private wealth services for both institutional and private clients.
The shares are trading at 1,294 pence, which leaves them 46 pence, or about 3.4%, under the 1,340 pence cash offer. That gap? Traders chalk it up to time left until closing, financing expenses, and the possibility that regulatory or other approvals might drag out.
Banks, asset managers, and event-driven funds are expected to reveal more as they move their positions in response to the bid. What matters for the market isn’t so much the list of holders, but whether the spread narrows when key milestones are hit.
There’s an obvious catch, though. Any delays in approval or timetable slippage can send the spread wider in a hurry. Should the deal collapse, the shares drop through the offer floor and would need to find new footing based on fundamentals.
Investors now await word on regulatory approvals and timing details. JTC’s full-year numbers land April 7.
